Literature DB >> 31489982

Chinese newborn screening for the incidence of G6PD deficiency and variant of G6PD gene from 2013 to 2017.

Zhidai Liu1,2,3,4,5, Chaowen Yu1,2,3,4,5, Qingge Li6, Ren Cai7, Yiping Qu8, Weipeng Wang9, Jie Wang10, Jinwen Feng11, Wenbin Zhu12, Mingcai Ou13, Weitong Huang14, Deguo Tang15, Wei Guo1,2,3,4,5, Fangjie Liu1,2,3,4,5, Yanhua Chen1,2,3,4,5, Lifang Fu1,2,3,4,5, Yanxia Zhou1,2,3,4,5, Wenqiong Lv1,2,3,4,5, Hang Zhang1,2,3,4,5, Juan Zhang1,2,3,4,5, Ming Wang1,2,3,4,5, Jing Yang1,2,3,4,5, Kexing Wan1,2,3,4,5, Jingkun Miao1,2,3,4,5, Zhaojian Yuan1,2,3,4,5, Hao Liu1,2,3,4,5, Xiaoyan He1,2,3,4,5, Wenjie Li16, Wengao Chen17, Lixin Ye18, Yajun Chen19, Shuodan Huang20, Haiping Liu21, Hongxiang Ding22, Xinhui Gan23, Shuyuan Wang24, Rong Qiang25, Minhong Gong26, Ping Teng27, Hua Wang28, Muping Zhou29, Hongwei Wei30, Xiangju Liu31, Kai Tang32, Yahong Ma33, Hongliang Wu34, Xiaoli Shu35, Yizhen Chen36, Danyan Zhuang37, Hui Li9, Zhi Liu9, Xiulian Liu10, Yao Chen12, Lidan Zhu22, Xiaoyan Zhu24, Caihong Mo11, Hua Tang28, Feng Yin31, Zhibing Shao34, Penghui Zhang1,2,3,4,5, Bin Peng37, Qing Lu38, Zhiguo Wang39, Lin Zou1,2,3,4,5.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the most common X-linked enzymopathies caused by G6PD gene variant. We aimed to provide the characteristics of G6PD deficiency and G6PD gene variant distribution in a large Chinese newborn screening population. We investigated the prevalence of G6PD in China from 2013 to 2017. Then, we examined G6PD activity and G6PD gene in representative Chinese birth cohort to explore the distribution of G6PD gene variant in 2016. We then performed multicolor melting curve analysis to classify G6PD gene variants in 10,357 neonates with activity-confirmed G6PD deficiency, and DNA Sanger sequencing for G6PD coding exons if hot site variants were not found. The screened population, organizations, and provinces of G6PD deficiency were increased from 2013 to 2017 in China. The top five frequency of G6PD gene variants were c.1376G>T, c.1388G>A, c.95A>G, c.1024C>T, and c.871G>A and varied in different provinces, with regional and ethnic features, and four pathogenic variant sites (c.152C>T, c.290A>T, c.697G>C, and c.1285A>G) were first reported. G6PD deficiency mainly occurs in South China, and the frequency of G6PD gene variant varies in different regions and ethnicities.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  G6PD; epidemiology; newborn screening; variant

Mesh:

Substances:

Year:  2019        PMID: 31489982     DOI: 10.1002/humu.23911

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  16 in total

1.  Molecular Characterization and Genotype-Phenotype Correlation of G6PD Mutations in Five Ethnicities of Northern Vietnam.

Authors:  Thi Thao Ngo; Thinh Huy Tran; Thanh Dat Ta; Thi Phuong Le; Phuoc Dung Nguyen; Mai Anh Tran; The-Hung Bui; Thanh Van Ta; Van Khanh Tran
Journal:  Anemia       Date:  2022-07-05

2.  G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost.

Authors:  Sameer Al-Abdi; Maryam Al-Aamri
Journal:  Hematol Oncol Stem Cell Ther       Date:  2020-04-18

3.  Genetic spectrum and clinical early natural history of glucose-6-phosphate dehydrogenase deficiency in Mexican children detected through newborn screening.

Authors:  Marcela Vela-Amieva; Miguel Angel Alcántara-Ortigoza; Ariadna González-Del Angel; Leticia Belmont-Martínez; Carlos López-Candiani; Isabel Ibarra-González
Journal:  Orphanet J Rare Dis       Date:  2021-02-26       Impact factor: 4.123

4.  Integrative identification of the pathogenic role of a novel G6PD missense mutation c.697G>C.

Authors:  Hongyang Zhang; Danyi Peng; Yi Shu; Dan Zhu; Weiwei Hu; Chaowen Yu; Juan Zhang; Shan Liu; Kexing Wan; Zhaojian Yuan; Hao Liu; Dongjuan Wang; Tingting Jiang; Jie Yu; Penghui Zhang; Lin Zou
Journal:  Ann Transl Med       Date:  2021-02

5.  Glucose-6-phosphate dehydrogenase mutations in malaria endemic area of Thailand by multiplexed high-resolution melting curve analysis.

Authors:  Usa Boonyuen; Duantida Songdej; Sasipa Tanyaratsrisakul; Suparat Phuanukoonnon; Kamonwan Chamchoy; Aun Praoparotai; Phonchanan Pakparnich; Sirapapha Sudsumrit; Thomas Edwards; Christopher T Williams; Rachel L Byrne; Emily R Adams; Mallika Imwong
Journal:  Malar J       Date:  2021-04-20       Impact factor: 2.979

6.  Application of a next-generation sequencing (NGS) panel in newborn screening efficiently identifies inborn disorders of neonates.

Authors:  Xinwen Huang; Dingwen Wu; Lin Zhu; Wenjun Wang; Rulai Yang; Jianbin Yang; Qunyan He; Bingquan Zhu; Ying You; Rui Xiao; Zhengyan Zhao
Journal:  Orphanet J Rare Dis       Date:  2022-02-21       Impact factor: 4.123

7.  Glucose-6-Phosphate dehydrogenase deficiency associated hemolysis in a cohort of new onset type 1 diabetes children in Guangdong province, China.

Authors:  Aijing Xu; Minyan Jiang; Wen Zhang; Yunting Lin; Yongxian Shao; Huifen Mei; Jing Cheng; Cuili Liang; Cuiling Li; Xiuzhen Li; Li Liu
Journal:  Diabetol Metab Syndr       Date:  2022-03-21       Impact factor: 3.320

8.  Genetic and Epigenetic Factors Co-Influence the Severity of Phenotypic Presentations in Compound G6PD Mutations

Authors:  Yee Yik Mot; Jay Suriar Rajasuriar; Hafizuddin Mohamed Fauzi; Emmanuel Jairaj Moses; Narazah Mohd Yusoff
Journal:  Turk J Haematol       Date:  2021-12-10       Impact factor: 1.831

9.  Glucose-6-phosphate dehydrogenase deficiency in the Han Chinese population: molecular characterization and genotype-phenotype association throughout an activity distribution.

Authors:  Ying He; Yinhui Zhang; Xionghao Chen; Qiong Wang; Lifen Ling; Yuhong Xu
Journal:  Sci Rep       Date:  2020-10-13       Impact factor: 4.379

10.  Epidemiology, evolutionary origin, and malaria-induced positive selection effects of G6PD-deficient alleles in Chinese populations.

Authors:  Yuzhong Zheng; Junli Wang; Xueyan Liang; Huiying Huang; Yanbo Ma; Liyun Lin; Chunfang Wang; Xiaofen Zhan; Liye Yang; Guangcai Zha; Peikui Yang; Xianghui Zou; Zikai Chen; Xinyao Chen; Weizhong Chen; Xiangzhi Liu; Min Lin
Journal:  Mol Genet Genomic Med       Date:  2020-10-31       Impact factor: 2.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.